Stock ADVAXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Advaxis, Inc. OTC Bulletin Board

Equities

US0076241092

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Advaxis, Inc.
Apr. 16 Ayala Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 16 Ayala Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stocks Futures Steady on Rates Optimism
DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh
DJ
ADVAXIS : Alliance Global Adjusts Advaxis' Price Target to $2.25 From $5, Maintains Buy Rating
MT
Advaxis Announces Updated Data at ASCO from a Phase 2 Study of AXAL in Advanced Cervical Cancer Showing Promising Survival Rates Consistent with Earlier Reports
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADXS Stock
  4. Stock
  5. News Advaxis, Inc.
  6. Analyst Reco.